Jaguar Health (NASDAQ:JAGX) Now Covered by Analysts at LADENBURG THALM/SH SH

Share on StockTwits

LADENBURG THALM/SH SH assumed coverage on shares of Jaguar Health (NASDAQ:JAGX) in a report released on Thursday morning, The Fly reports. The brokerage issued a buy rating and a $5.00 target price on the biotechnology company’s stock.

Several other equities analysts have also recently weighed in on JAGX. Zacks Investment Research cut Jaguar Health from a buy rating to a hold rating in a report on Thursday, August 15th. ValuEngine upgraded Jaguar Health from a hold rating to a buy rating in a report on Thursday, August 1st. Finally, HC Wainwright set a $10.00 target price on Jaguar Health and gave the stock a buy rating in a report on Tuesday, July 2nd.

Shares of NASDAQ JAGX traded up $0.02 during trading on Thursday, hitting $1.33. The company had a trading volume of 1,172,425 shares, compared to its average volume of 440,586. The stock has a 50 day simple moving average of $1.36 and a 200 day simple moving average of $1.54. The firm has a market capitalization of $51.00 million, a P/E ratio of -0.01 and a beta of 0.74. Jaguar Health has a 12 month low of $1.00 and a 12 month high of $175.00. The company has a debt-to-equity ratio of 0.02, a quick ratio of 0.24 and a current ratio of 0.35.

In related news, Director James J. Bochnowski bought 180,582 shares of the company’s stock in a transaction dated Tuesday, July 23rd. The stock was purchased at an average price of $2.00 per share, for a total transaction of $361,164.00. The purchase was disclosed in a legal filing with the SEC, which is accessible through the SEC website. 1.81% of the stock is currently owned by insiders.

Jaguar Health Company Profile

Jaguar Health, Inc, a commercial stage natural-products pharmaceuticals company, focuses on developing gastrointestinal products for human prescription use and animals worldwide. The company, through its wholly-owned subsidiary, Napo Pharmaceuticals, Inc, focuses on developing and commercializing proprietary human gastrointestinal pharmaceuticals for the global marketplace from plants used traditionally in rainforest areas.

Featured Article: What is Net Asset Value (NAV)?

The Fly

Receive News & Ratings for Jaguar Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Jaguar Health and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


 
© 2006-2019 BBNS.